Date published: 2026-6-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

Lefty Inhibitors

Lefty inhibitors belong to a distinct class of chemical compounds known for their pivotal role in regulating embryonic development and cell differentiation. These inhibitors are closely associated with the transforming growth factor-beta (TGF-β) superfamily of signaling molecules. To understand Lefty inhibitors, it's essential to appreciate their role within the intricate process of embryogenesis. During early development, Lefty inhibitors play a fundamental role in establishing the body plan of an organism. They are known for their function in maintaining symmetry and axis formation, a critical step in the early stages of embryonic development. Lefty inhibitors act as antagonists to certain signaling pathways within the TGF-β superfamily, exerting their influence by interfering with the signaling molecules involved. Specifically, they counteract the activity of Nodal, an important TGF-β member, which plays a key role in specifying the left-right axis in vertebrates. By doing so, Lefty inhibitors help ensure that the developing embryo forms with appropriate bilateral symmetry, preventing developmental abnormalities and ensuring the proper organization of vital organs.

Lefty inhibitors can be broadly classified into two isoforms: Lefty-1 and Lefty-2. Both isoforms exhibit similar mechanisms of action, working as negative regulators by binding to Nodal and inhibiting its signaling. This function is crucial for maintaining the balance of the Nodal pathway, preventing excessive or inappropriate signaling that could lead to developmental defects. Lefty inhibitors are a prime example of the delicate checks and balances that govern embryonic development. Their presence ensures the precise orchestration of signaling pathways, guaranteeing that an organism's body plan and symmetry are established correctly during its early stages of development. Understanding the mechanisms of Lefty inhibitors is not only essential for developmental biology but also holds potential implications for various fields of science and medicine, shedding light on the intricacies of cell signaling and differentiation.

SEE ALSO...

Items 11 to 15 of 15 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$36.00
$117.00
$525.00
26
(1)

Given the cross-talk between Wnt and TGF-β signaling, inhibitors like XAV-939 or ICG-001 might indirectly modulate LEFTY expression or activity.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$117.00
$423.00
11
(1)

Vemurafenib specifically inhibits BRAF V600E mutations, halting the uncontrolled proliferation of melanoma cells with this specific mutation.

Regorafenib

755037-03-7sc-477163
sc-477163A
25 mg
50 mg
$320.00
$430.00
3
(0)

Regorafenib is a multi-kinase inhibitor targeting angiogenic receptors, stromal kinases, and oncogenic kinases, which helps control growth and angiogenesis.

Osimertinib

1421373-65-0sc-507355
5 mg
$86.00
(0)

Osimertinib is an EGFR tyrosine kinase inhibitor designed to target EGFR T790M mutations, overcoming resistance in non-small cell lung (NSCLC) patients.

5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine

1032900-25-6sc-505041
1 mg
$230.00
(0)

Ceritinib inhibits ALK and ROS1 kinases, specifically studied in the research of non-small cell (NSCLC) with ALK or ROS1 gene rearrangements, blocking tumor growth.